Homoeopathy in Children with Intellectual Disability
Phase 3
- Conditions
- Health Condition 1: F71- Moderate intellectual disabilities
- Registration Number
- CTRI/2020/01/023017
- Lead Sponsor
- Central Council for Research in Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children diagnosed with Borderline intelligence or Mild to Moderate Intellectual disability on the basis of assessments by NIEPMD, Chennai
Exclusion Criteria
Children diagnosed with severe to profound Intellectual disability; with progressive uncontrolled disease of any organ system with deteriorating cardiac, renal, neurological functioning as ascertained clinical or with laboratory investigations and children with malignancies or currently under treatment for malignancies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie homoeopathy's effects on F71 moderate intellectual disabilities in children?
How does homoeopathy compare to standard-of-care treatments for F71 moderate intellectual disabilities in pediatric patients?
Are there specific biomarkers that predict response to homoeopathic interventions in children with F71 moderate intellectual disabilities?
What are the known or potential adverse events associated with homoeopathic treatment in F71 moderate intellectual disability trials?
What related compounds or combination therapies are being explored alongside homoeopathy for F71 moderate intellectual disabilities?